Chemotherapy intensity importace in concurrent chemoradiotherapy of locally advanced cervical cancer;Význam intenzity chemoterapie v konkomitantní chemoradioterapii lokálně pokročilého karcinomu hrdla děložního

Ceska Gynekologie

Volumn 71, Issue 4, 2006, Pages 308-311

  Sirák, Igor ^a,b   Petera, J ^a   Odrazka K ^a   Dolezel M ^a   Zoul, Z ^a   Vaculikova M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Cervical carcinoma; Cisplatin; Concurrent chemoradiotherapy; Leukopenia

Indexed keywords

CISPLATIN;

ANEMIA; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEMATEMESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOPENIA; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; UTERINE CERVIX CANCER; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; RADIOTHERAPY DOSAGE; UTERINE CERVICAL NEOPLASMS;

EID: 33747406281     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Green, J.A., Kirwan, J.M., Tierney, J.J., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet, 2001, 358(9284), p. 781-786.
2. Mitsuhashi, A., Uno, T., Tanaka, N., et al. Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma. Gynecol. Oncology, 2005, 96, 1, p. 194-197.
3. Morris, M., Eifel, P.J., Lu, J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N. Engl. J. Med., 1999, 340, 15, p. 1137-1143.
4. Park, T.K., Kim, S.N., Kim, S.W., et al. Concurrent chemotherapy and radiotherapy in invasive cervical cancer patients with high risk factors. J. Korean. Med. Sci., 2000, 15, 4, p. 436-441.
5. Pearcey, R., Brundage, M., Drouin, P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J. Clin. Oncol., 2002, 20, 4, p. 966-972.
6. Petera, J., Odrážka, K., Frgala, T., Špaček, J. External beam radiotherapy and high-dose brachytherapy combined with cisplatin and paclitaxel in patients with advanced cervical carcinoma. Gynecol. Oncology, 2005, 99, 2, p. 334-338.
7. Rose, P.G., Bundy, B.N., Watkins, E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med., 1999, 340, 15, p. 1144-1153.
8. Rose, P.G. Chemoradiotherapy: the new standard care for invasive cervical cancer. Drugs, 2000, 60, 6, p. 1239-1244.
9. Serkies, K., Jassem, J. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity. Int. J. Radiat. Oncol. Biol. Phys., 2004, 60, 3, p. 814-821.
10. Schilder, J.M., Stehman, F.B. Concurrent chemotherapy and radiation therapy in primary cancer of the cervix. Curr. Oncol. Rep., 1999, 1, p. 41-46.
11. Strauss, H.G., Kuhnt, T., Laban, C., et al. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Strahlenther Onkol., 2002, 178, 7, p. 378-385.
12. Thomas, G.M. Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin. Radiat. Oncol., 2000, 10, 1, p. 44-50.
13. Toita, T., Moromizato, H., Ogawa, K., et al. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer. Gynecol. Oncology, 2005, 96, 3, s. 665-670.